Clinical Trial Update: Postprandial Lipoproteins and Atherosclerosis

View source ↗

Summary

Columbia University sponsored a completed clinical trial investigating postprandial lipoproteins and atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Carotid Artery Disease
• Heart Diseases
• Myocardial Ischemia

Snippet

Sponsor: Columbia University | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED